Art

J-GLOBAL ID：202202245642099079   Reference number：22A2309139

The Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol in the Treatment of COPD in the Elderly

高齢者のCOPD治療におけるブデソニド/グリコピロニウム/ホルモテロールの有効性と安全性【JST・京大機械翻訳】

Author (3)： Guo Min (Department of Respiration, General Hospital of Pingxiang Mining Industry Group Co., Ltd, Pingxiang 337000, China) ,  Yu Chuan (Department of Respiration, General Hospital of Pingxiang Mining Industry Group Co., Ltd, Pingxiang 337000, China) ,  Li Zenian (Department of Respiration, General Hospital of Pingxiang Mining Industry Group Co., Ltd, Pingxiang 337000, China)
Material： Contrast Media & Molecular Imaging
Volume： 2022  Page： Null  Publication year： 2022 
JST Material Number： W2544A  ISSN： 1555-4309  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Objective. Chronic obstructive...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A2309139&from=J-GLOBAL&jstjournalNo=W2544A") }}

Thesaurus term： document retrieval ,  hypertension ,  respiratory organ ,  mortality ,  pneumonia ,  elderly person ,  effectiveness ,  vital capacity ,  Web(information system) ,  *chronic obstructive pulmonary disease
Semi thesaurus term： FEV1 ,  慢性化 ,  探索戦略 , 【Automatic Indexing@JST】

JST classification (2)： Drug therapy(=pharmacotherapy)for respiratory system diseases  (GI05020J) ,  Clinical application of drugs acting on respiration and respiratory system  (GW08020U)

Reference (50)：

• B. Alcázar-Navarrete, J. M. Díaz-Lopez, P. García-Flores, M. Ortega-Antelo, I. Aguilar-Cruz, O. Ruiz-Rodríguez, P. Santiago-Diaz, P. J. Romero Palacios, "T2 biomarkers as predictors of exacerbations of chronic obstructive pulmonary disease," Arch Bronconeumol, vol. 58, no. 8, pp. 495-600, 2021.
• S. D. Anker, L. E. Sander, D. H. Fitchett, B. Zinman, A. Pernille Ofstad, C. Wanner, O. Vedin, S. Lauer, S. Verma, H. K. Yaggi, S. E. Inzucchi, "Empagliflozin in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease," Diabetes Res Clin Pract, vol. 186, 2022.
• K. Brassington, S. Selemidis, S. Bozinovski, R. Vlahos, "Chronic obstructive pulmonary disease and atherosclerosis: common mechanisms and novel therapeutics," Clinical Science, vol. 136, no. 6, pp. 405-423, 2022.
• Y. Y. Cheng, S. Y. Lin, C. Y. Hsu, P. K. Fu, "Respiratory muscle training can improve cognition, lung function, and diaphragmatic thickness fraction in male and non-obese patients with chronic obstructive pulmonary disease: a prospective study," J Pers Med, vol. 12, no. 3, pp. 475, 122022.
• F. P. Chmiel, D. K. Burns, J. B. Pickering, A. Blythin, T. M. Wilkinson, M. J. Boniface, "Prediction of chronic obstructive pulmonary disease exacerbation events by using patient self-reported data in a digital health app: statistical evaluation and machine learning approach," JMIR Med Inform, vol. 10, no. 3, 2022.

Terms in the title (6)： COPD ,  治療 ,  ブデソニド ,  ホルモテロール ,  有効性 ,  安全性